Encouraging the spread of innovation for blood cancer in Europe

The EU’s Beating Cancer plan states that unless we take action, lives lost to cancer in Europe are set to increase by more than 24 percent by 2035, and it wants to see greater use of approved innov…

POLITICO
What’s in a name? Why unmet medical needs are riling the pharma industry 

The EU wants to steer drug development to cover research gaps, but industry hates the idea.

POLITICO
What single market? Why Romanians get new medicines 2 years after Germans

Not all patients are equal when it comes to treatment with cutting-edge drugs.

POLITICO
Groundbreaking ceremony for the new building of the Helmholtz Institute for Translational Oncology #HI-TRON in Mainz (Germany), providing a space for novel cutting-edge #immunotherapy development, #personalizedmedicines and #mRNAs as tools in #cancer #research @mainz_de @unimainz @helmholtz @hereon @dkfz
https://www.dkfz.de/de/presse/pressemitteilungen/2023/dkfz-pm-23-33a-HI-TRON-Mainz-ein-Helmholtz-Institut-des-DKFZ-erhaelt-neues-Gebaeude.php
Innovation is the foundation of resilient health care systems

R&D to discover, develop and deliver transformative medicines that address important treatment gaps in severe illnesses, at a speed that rapidly and appropriately meets our communities’ health…

POLITICO
Transformer les miracles de la science en réalité pour les patients dans le monde

POLITICO Studio a interviewé Brendan O’Callaghan, Vice-Président Exécutif des Affaires Industrielles Globales à Sanofi

POLITICO
Turning miracles of science into reality for patients

Q&A: POLITICO Studio interviews Brendan O’Callaghan, Executive Vice President for Global Industrial Affairs at Sanofi

POLITICO